{
    "clinical_study": {
        "@rank": "126118", 
        "arm_group": [
            {
                "arm_group_label": "30-gauge needle", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects will be screened, assessed, and randomized to be injected with onabotulinum toxin A using a 30-gauge needle on one side of the face and injected using a 32-gauge needle on the other side during their first clinic visit. All needles would be luer lock, \u00bd inch length, and attached to separate 1cc syringes. Injection depth would be 1-2mm, dermal, and the angle of incidence would be perpendicular."
            }, 
            {
                "arm_group_label": "32-gauge needle", 
                "arm_group_type": "Active Comparator", 
                "description": "Subjects will be screened, assessed, and randomized to be injected with onabotulinum toxin A using a 30-gauge needle on one side of the face and injected using a 32-gauge needle on the other side during their first clinic visit. All needles would be luer lock, \u00bd inch length, and attached to separate 1cc syringes. Injection depth would be 1-2mm, dermal, and the angle of incidence would be perpendicular."
            }
        ], 
        "brief_summary": {
            "textblock": "The purpose of this study is to compare the levels of pain resulting from injections of\n      Botox\u00ae for wrinkles on the forehead and between the eyes using two different sized needles\n      (32 gauge and 30 gauge needles)."
        }, 
        "brief_title": "A Pilot Study of Needle Size and Pain Perception With Botulinum Toxin A Injections", 
        "completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Pain", 
        "detailed_description": {
            "textblock": "Subjects will be screened, assessed, and randomized to be injected with onabotulinum toxin A\n      using a 30-gauge needle on one side of the face and injected using a 32-gauge needle on the\n      other side during their first clinic visit. This study is a pilot study designed to\n      determine feasibility of these procedures."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          1. In good health\n\n          2. Is a female\n\n          3. Is 25-70 years of age\n\n          4. Has moderate dynamic forehead/glabellar wrinkles\n\n          5. Has willingness and the ability to understand and provide informed consent and\n             communicate with the study staff\n\n        Exclusion Criteria:\n\n          1. Younger than 25 or older than 70 years of age\n\n          2. Pregnant or lactating\n\n          3. Is a male\n\n          4. Has received the following treatments in the forehead or glabellar region:\n\n               1. botulinum toxin injections in the past 6 months\n\n               2. ablative laser procedure in the past 6 months\n\n               3. radiofrequency device treatment in the past 6 months\n\n               4. ultrasound device treatment in the past 6 months\n\n               5. medium to deep chemical peel in the past 6 months\n\n               6. temporary soft tissue augmentation material in the area to be treated in the\n                  past year\n\n               7. semi-permanent soft tissue augmentation material in the area to be treated in\n                  the past 2 years\n\n               8. permanent soft tissue augmentation material in the area to be treated\n\n          5. Has an active infection in the forehead or glabellar region (excluding mild acne)\n\n          6. Is allergic to cow's-milk protein\n\n          7. Is allergic to albumin\n\n          8. Taking aminoglycoside\n\n          9. Is currently using anticoagulation therapy\n\n         10. Has a history of bleeding disorders\n\n         11. Has a mental illness\n\n         12. Unable to understand the protocol or to give informed consent"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "70 Years", 
            "minimum_age": "25 Years"
        }, 
        "enrollment": {
            "#text": "20", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01981174", 
            "org_study_id": "STU84470"
        }, 
        "intervention": [
            {
                "arm_group_label": "30-gauge needle", 
                "intervention_name": "30-gauge needle", 
                "intervention_type": "Procedure"
            }, 
            {
                "arm_group_label": "32-gauge needle", 
                "intervention_name": "32-gauge needle", 
                "intervention_type": "Procedure"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Botulinum Toxins, Type A", 
                "Botulinum Toxins"
            ]
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "December 17, 2013", 
        "location": {
            "contact": {
                "email": "research.nuderm@norhtwestern.edu", 
                "last_name": "Emily Poon, PhD", 
                "phone": "312-695-4761"
            }, 
            "facility": {
                "address": {
                    "city": "Chicago", 
                    "country": "United States", 
                    "state": "Illinois", 
                    "zip": "60611"
                }, 
                "name": "Northwestern University Department of Dermatology"
            }, 
            "investigator": {
                "last_name": "Murad Alam, MD", 
                "role": "Principal Investigator"
            }, 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "United States"
        }, 
        "number_of_arms": "2", 
        "official_title": "The Effect of Needle Size on Pain Perception in Patients Treated With Botulinum Toxin A Injections", 
        "overall_contact": {
            "email": "research.nuderm@northwestern.edu", 
            "last_name": "Emily Poon, PhD", 
            "phone": "312-695-4761"
        }, 
        "overall_official": {
            "affiliation": "Northwestern University", 
            "last_name": "Murad Alam, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "January 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Subjects will rate pain using the visual analog score (VAS 1-10) after each side is injected using the 30 or 32 gauge needles.  Lower values represents less pain; higher values represents more pain.", 
            "measure": "Visual analog score (VAS) pain rating after each side is injected", 
            "safety_issue": "No", 
            "time_frame": "1 hour on Treatment day"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01981174"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Northwestern University", 
            "investigator_full_name": "Murad Alam", 
            "investigator_title": "Professor in Dermatology, Otolaryngology - Head and Neck Surgery, and Surgery-Organ Transplantation", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Northwestern University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Northwestern University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Allocation: Randomized, Intervention Model: Single Group Assignment, Masking: Double Blind (Subject, Investigator, Outcomes Assessor)", 
        "study_type": "Interventional", 
        "verification_date": "December 2013"
    }
}